This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub
Menu

Michael Byrne, Ph.D.
Director of In vivo Biology and Ophthalmology at Wave Life Sciences
Speaker

Agenda Sessions

  • Stereopure Oligonucleotides Produce Potent and Durable Activity in the Eye Supporting Their Development for Inherited Retinal Diseases

    On Demand - Premium Only
    View Session

At this event

Prev
Next
Vanessa Carle
Postdoctoral Researcher
EPFL (École polytechnique fédérale de La

See Michael at TIDES: Oligonucleotide & Peptide Therapeutics Content Hub